Cargando…

Safety and Efficacy of Gadobutrol-Enhanced MRI in Patients Aged Under 2 Years—A Single-Center, Observational Study

Gadobutrol is a 1-molar gadolinium-based contrast agent with well-characterized safety and efficacy for magnetic resonance imaging (MRI) in adults and children ≥ 2 years old. This observational study assessed gadobutrol-enhanced MRI in children < 2 years of age. Sixty infants (mean age 11.1 month...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhargava, Ravi, Noga, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089836/ https://www.ncbi.nlm.nih.gov/pubmed/25114540 http://dx.doi.org/10.4137/MRI.S10996

Ejemplares similares

Gadobutrol: A Review in Contrast-Enhanced MRI and MRA
por: Scott, Lesley J.
Publicado: (2018)

Gadobutrol in India—A Comprehensive Review of Safety and Efficacy
por: Endrikat, Jan, et al.
Publicado: (2017)

Time optimization of gadobutrol-enhanced brain MRI for metastases and primary tumors using a dynamic contrast-enhanced imaging
por: Seo, Jeemin, et al.
Publicado: (2022)

Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study
por: Glutig, Katja, et al.
Publicado: (2016)

Gadobutrol: Fatal anaphylaxis: case report
Publicado: (2021)

A Case of a Huge Inferior Vena Cava Leiomyosarcoma: Precise Preoperative Evaluation with Gadobutrol-Enhanced MRI
por: Zhou, Xiaoqi, et al.
Publicado: (2020)

Gadobutrol Precedes Gd-DTPA in Abdominal Contrast-Enhanced MRA and MRI: A Prospective, Multicenter, Intraindividual Study
por: Liu, Xijiao, et al.
Publicado: (2019)

Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
por: Franckenberg, Sabine, et al.
Publicado: (2017)

Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols
por: Halvorsen, Merete, et al.
Publicado: (2020)

Brain deposition of gadobutrol in children—a cross-sectional and longitudinal MRI T1 mapping study
por: Gräfe, Daniel, et al.
Publicado: (2022)

High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
por: D’Angelo, Tommaso, et al.
Publicado: (2017)

A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System
por: TANAKA, Akio, et al.
Publicado: (2015)

Gadobutrol in Renally Impaired Patients: Results of the GRIP Study
por: Michaely, Henrik J., et al.
Publicado: (2017)

Safety of gadobutrol: results of a non-interventional study of 3710 patients, including 404 children
por: Glutig, Katja, et al.
Publicado: (2018)

Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study
por: Gutierrez, Juan E, et al.
Publicado: (2015)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

Correction to “Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study”
por: Gutierrez, Juan E, et al.
Publicado: (2015)

Effect of Imaging Time in the Magnetic Resonance Detection of Intracerebral Metastases Using Single Dose Gadobutrol
por: Jeon, Ji-Young, et al.
Publicado: (2014)

Half-Dose versus Single-Dose Gadobutrol for Extracellular Volume Measurements in Cardiac Magnetic Resonance
por: Doeblin, Patrick, et al.
Publicado: (2023)

Comparison of Multidetector CT and Gadobutrol-Enhanced MR Imaging for Evaluation of Small, Solid Pancreatic Lesions
por: Choi, Tae Won, et al.
Publicado: (2016)

Gadobutrol-enhanced magnetic resonance imaging of meningeal carcinomatosis: case report with emphasis on early diagnosis
por: Pan, Xinfa, et al.
Publicado: (2016)

The TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement analysis
por: Kuhn, Matthew J., et al.
Publicado: (2021)

Anaphylaxis to gadobutrol and gadoterate meglumine in a patient with low grade astrocytoma
por: Montalvo, Juan Manuel Escobar, et al.
Publicado: (2014)

Longitudinal Assessment of Dentate Nuclei Relaxometry during Massive Gadobutrol Exposure
por: Tedeschi, Enrico, et al.
Publicado: (2017)

Single-Dose Gadobutrol in Comparison With Single-Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 T
por: Wildgruber, Moritz, et al.
Publicado: (2014)

Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study
por: Prince, Martin R., et al.
Publicado: (2016)

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
por: Elmholdt, Tina Rask, et al.
Publicado: (2010)

Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood
por: Eide, Per K., et al.
Publicado: (2021)

Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol
por: Ringstad, Geir, et al.
Publicado: (2023)

Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications
por: Endrikat, Jan, et al.
Publicado: (2016)

A Comparison of Low-Dose and Normal-Dose Gadobutrol in MR Renography and Renal Angiography
por: Bayrak, Ilkay Koray, et al.
Publicado: (2008)

Gadolinium Accumulation and Toxicity on In Vitro Grown Stevia rebaudiana: A Case-Study on Gadobutrol
por: Scurtu, Violeta Florina, et al.
Publicado: (2022)

What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?
por: Agris, Jacob, et al.
Publicado: (2015)

A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study
por: Tandon, Animesh, et al.
Publicado: (2016)

The effects of extracellular contrast agent (Gadobutrol) on the precision and reproducibility of cardiovascular magnetic resonance feature tracking
por: Kuetting, Daniel L. R., et al.
Publicado: (2016)

Decreased native renal T(1) up to one week after gadobutrol administration in healthy volunteers
por: de Boer, Anneloes, et al.
Publicado: (2019)

Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain
por: Anderhalten, Lina, et al.
Publicado: (2022)

Safety and efficacy of the novel motorized power spiral enteroscopy: A single‐center experience
por: Singh, Pankaj, et al.
Publicado: (2022)

MRI with ferumoxytol: A single center experience of safety across the age spectrum
por: Nguyen, Kim‐Lien, et al.
Publicado: (2016)

Prospective, randomized comparison of gadopentetate and gadobutrol to assess chronic myocardial infarction applying cardiovascular magnetic resonance
por: Rudolph, Andre, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mhmfeoet9bil9b7j89p1d2hb28